Adrenergic pharmacology and cognition: Focus on the prefrontal cortex
Top Cited Papers
- 28 December 2006
- journal article
- review article
- Published by Elsevier in Pharmacology & Therapeutics
- Vol. 113 (3), 523-536
- https://doi.org/10.1016/j.pharmthera.2006.11.006
Abstract
No abstract availableKeywords
This publication has 161 references indexed in Scilit:
- Evaluation of a Susceptibility Gene for Schizophrenia: Genotype Based Meta-Analysis of RGS4 Polymorphisms from Thirteen Independent SamplesBiological Psychiatry, 2006
- Genetic polymorphisms of the RGS4 and dorsolateral prefrontal cortex morphometry among first episode schizophrenia patientsMolecular Psychiatry, 2004
- Treatment with the Noradrenergic Alpha-2 Agonist Clonidine, But Not Diazepam, Improves Spatial Working Memory in Normal Young Rhesus MonkeysNeuropsychopharmacology, 1999
- Gene targeting — homing in on α2-adrenoceptor-subtype functionTrends in Pharmacological Sciences, 1997
- The role of hippocampus and frontal cortex in age- related memory changesNeuroReport, 1996
- Delayed-response deficit induced by local injection of the α2-adrenergic antagonist yohimbine into the dorsolateral prefrontal cortex in young adult monkeysBehavioral and Neural Biology, 1994
- Pharmacological Manipulations of the ??2-Noradrenergic SystemDrugs & Aging, 1994
- Adrenergic receptors, G proteins, and cell regulation: implications for aging researchExperimental Gerontology, 1993
- Effects of medetomidine, an α-2 adrenoceptor agonist, and atipamezole, an α-2 antagonist, on spatial memory performance in adult and aged ratsBehavioral and Neural Biology, 1992
- The effects of guanfacine, α-2 agonist, on the performance of young and aged rats in spatial navigation taskBehavioral and Neural Biology, 1991